Skip to content

Bladder Cancer Detection Using Convolutional Neural Networks

Bladder Cancer Detection Using Convolutional Neural Networks

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05193656
Acronym
BLAInostic
Enrollment
5000
Registered
2022-01-18
Start date
2021-06-01
Completion date
2026-06-01
Last updated
2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Keywords

Machine learning, Artificial intelligence

Brief summary

The investigators aim to experiment and implement various deep learning architectures to achieve human-level accuracy in Computer-aided diagnosis (CAD) systems. In particular, the investigators are interested in detecting bladder tumors from CT urography scans and cystoscopies of the bladder in this project.

Detailed description

The investigators aim to experiment and implement various deep learning architectures to achieve human-level accuracy in Computer-aided diagnosis (CAD) systems. In particular, the investigators are interested in detecting bladder tumors from CT urography scans and cystoscopies of the bladder in this project. The investigators want to classify bladder tumors as cancer, non cancer, high grade and low grade, invasive and non-invasive, with high sensitivity and low false positive rate using various convolutional neural networks (CNN). This task can be considered as the first step in building CAD systems for bladder cancer diagnosis. Moreover, by automating this task, the investigator scan significantly reduce the time for the radiologists to create large-scale labeled datasets of CT-urography scans and reduce the false-negative and positive that can happen due to human evaluation cystoscopies.

Interventions

DIAGNOSTIC_TESTAl_bladder

Detection of bladder tumor with help of Artificial intelligence

Sponsors

Zealand University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with first time hematuria * Patients with the control program for previous bladder cancer

Exclusion criteria

* Patients with control cystoscope for noncancer suspected disease

Design outcomes

Primary

MeasureTime frameDescription
Comparing standard technique to Machine Learning5 yearsThe accuracy of Machine learning to detect bladder cancer compared to standard cystoscopy

Secondary

MeasureTime frameDescription
Detecting accuracy of subtypes of bladder cancer5 yearsThe abelity of Machine Learning to identify high grad bladder cancer from low grad bladder cancer

Countries

Denmark

Contacts

Primary ContactNessn Azawi, phd
nesa@regionsjaelland.dk26393034

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026